ANIXA BIOSCIENCES, INC. Adjustments to Additional Paid in Capital, Warrant Issued
ANIXA BIOSCIENCES, INC. (ANIX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $22.00 thousand for the 3-month period ending 2024-04-30, per its 10-Q filed 2024-06-04.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2024-06-04
- ANIXA BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-04-30 was $22.00K, a 53.19% decline year-over-year.
- ANIXA BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-01-31 was $56.00K, a 30.86% decline year-over-year.
- ANIXA BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-04-30 was $47.00K.
- ANIXA BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-01-31 was $81.00K.
- ANIXA BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $221.00K, a 66.26% decline from fiscal 2022.
- ANIXA BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $655.00K.
- ANIXA BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2014 was $513.11K, a 131.15% increase from fiscal 2013.
- ANIXA BIOSCIENCES, INC. adjustments to additional paid in capital, warrant issued for fiscal 2013 was $221.99K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2024-04-30 | $22.00K 10-Q · filed 2024-06-04 | $78.00K 10-Q · filed 2024-06-04 | ||
| 2024-01-31 | $56.00K 10-Q · filed 2024-03-12 | |||
| 2023-10-31 | $221.00K 10-K · filed 2024-01-16 | |||
| 2023-04-30 | $47.00K 10-Q · filed 2024-06-04 | $128.00K 10-Q · filed 2024-06-04 | ||
| 2023-01-31 | $81.00K 10-Q · filed 2024-03-12 | |||
| 2022-10-31 | $655.00K 10-K · filed 2024-01-16 | |||
| 2018-07-31 | $57.05K 10-Q · filed 2018-09-07 | |||
| 2014-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-12-23 | $0.00 derived: sum of 2 quarters · filed 2015-12-23 | $0.00 derived: sum of 3 quarters · filed 2015-12-23 | $513.11K 10-K · filed 2015-12-23 |
| 2014-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $0.00 derived: sum of 2 quarters · filed 2014-09-15 | $513.11K 10-Q · filed 2014-09-15 | $513.11K derived: sum of 4 quarters · filed 2015-01-29 |
| 2014-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-16 | $513.11K 10-Q · filed 2014-06-16 | $513.11K derived: sum of 3 quarters · filed 2015-01-29 | $513.11K derived: sum of 4 quarters · filed 2015-01-29 |
| 2014-01-31 | $513.11K 10-Q · filed 2014-03-17 | $513.11K derived: sum of 2 quarters · filed 2015-01-29 | $513.11K derived: sum of 3 quarters · filed 2015-01-29 | $513.11K derived: sum of 4 quarters · filed 2015-01-29 |
| 2013-10-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-01-29 | $0.00 derived: sum of 2 quarters · filed 2015-01-29 | $0.00 derived: sum of 3 quarters · filed 2015-01-29 | $221.99K 10-K · filed 2015-01-29 |
| 2013-07-31 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2013-09-20 | $0.00 derived: sum of 2 quarters · filed 2013-09-20 | $221.99K 10-Q/A · filed 2013-09-20 | |
| 2013-04-30 | $0.00 derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2013-06-19 | $221.99K 10-Q/A · filed 2013-06-19 | ||
| 2013-01-31 | $221.99K 10-Q/A · filed 2013-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |